Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
<h4>Background</h4>Immune checkpoint inhibitors (ICIs) are highly effective in treating cancer; however, cardiotoxicity can occur, including myocarditis. Cardiac magnetic resonance (CMR) imaging is useful for evaluation of myocarditis, although it has not been well studied in ICI cardiot...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d60485952e1846e2a5ebdde4efb2f722 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d60485952e1846e2a5ebdde4efb2f722 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d60485952e1846e2a5ebdde4efb2f7222021-12-02T20:11:27ZLeft ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.1932-620310.1371/journal.pone.0246764https://doaj.org/article/d60485952e1846e2a5ebdde4efb2f7222021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0246764https://doaj.org/toc/1932-6203<h4>Background</h4>Immune checkpoint inhibitors (ICIs) are highly effective in treating cancer; however, cardiotoxicity can occur, including myocarditis. Cardiac magnetic resonance (CMR) imaging is useful for evaluation of myocarditis, although it has not been well studied in ICI cardiotoxicity.<h4>Methods</h4>We identified patients referred for CMR evaluation of ICI cardiotoxicity from September 2015 through September 2019. We assessed structural and functional parameters, feature tracking (FT) left ventricular and atrial strain, T2- weighted ratios and quantitative late gadolinium enhancement (LGE). We also applied the Updated Lake Louise Criteria for diagnosis of myocarditis.<h4>Results</h4>Of the 20 patients referred, the median left ventricular ejection fraction (LVEF) was 52.5% ± 19.1 and 50% had a normal LVEF (≥53%). FT strain analysis revealed an average abnormal global longitudinal strain (GLS) of -9.8%± 4.2%. In patients with a normal LVEF, the average GLS remained depressed at -12.3%± 2.4%. In all patients, GLS demonstrated a significant negative correlation with LVEF (rs = -0.64, p 0.002). Sixteen patients (80%) had presence of LGE (14 non-ischemic pattern and 2 ischemic). Percent LGE did not correlate with any CMR parameters and notably did not correlate with LVEF (rs = -0.29, p = 0.22) or GLS (rs = 0.10, p = 0.67), highlighting the value of tissue characterization beyond functional assessment. Nine patients (45%) met full Updated Lake Louise Criteria and 85% met at least one criterion, suggestive of myocarditis in the correct clinical context. Thirteen patients (65%) were treated for ICI-associated myocarditis and, of these, 54% (n = 7) had recovery of LVEF to normal. There was no correlation between LVEF (p = 0.47), GLS (0.89), or % LGE (0.15) and recovery of LVEF with treatment.<h4>Conclusion</h4>In patients with suspected ICI cardiotoxicity, CMR is an important diagnostic tool, even in the absence of overt left ventricular dysfunction, as abnormalities in left ventricular strain, T2 signal and LGE can identifying disease.Angela Y HigginsAmit ArbuneAaron SouferElio RaghebJennifer M KwanJerome LamyMariana HenryJason R CuomoAhmad CharifaCesia GallegosSarah HullJessica Shank CovielloAnna S BaderDana C PetersSteffen HuberHamid R MojibianAlbert J SinusasHarriet KlugerLauren A BaldassarrePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 2, p e0246764 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Angela Y Higgins Amit Arbune Aaron Soufer Elio Ragheb Jennifer M Kwan Jerome Lamy Mariana Henry Jason R Cuomo Ahmad Charifa Cesia Gallegos Sarah Hull Jessica Shank Coviello Anna S Bader Dana C Peters Steffen Huber Hamid R Mojibian Albert J Sinusas Harriet Kluger Lauren A Baldassarre Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. |
description |
<h4>Background</h4>Immune checkpoint inhibitors (ICIs) are highly effective in treating cancer; however, cardiotoxicity can occur, including myocarditis. Cardiac magnetic resonance (CMR) imaging is useful for evaluation of myocarditis, although it has not been well studied in ICI cardiotoxicity.<h4>Methods</h4>We identified patients referred for CMR evaluation of ICI cardiotoxicity from September 2015 through September 2019. We assessed structural and functional parameters, feature tracking (FT) left ventricular and atrial strain, T2- weighted ratios and quantitative late gadolinium enhancement (LGE). We also applied the Updated Lake Louise Criteria for diagnosis of myocarditis.<h4>Results</h4>Of the 20 patients referred, the median left ventricular ejection fraction (LVEF) was 52.5% ± 19.1 and 50% had a normal LVEF (≥53%). FT strain analysis revealed an average abnormal global longitudinal strain (GLS) of -9.8%± 4.2%. In patients with a normal LVEF, the average GLS remained depressed at -12.3%± 2.4%. In all patients, GLS demonstrated a significant negative correlation with LVEF (rs = -0.64, p 0.002). Sixteen patients (80%) had presence of LGE (14 non-ischemic pattern and 2 ischemic). Percent LGE did not correlate with any CMR parameters and notably did not correlate with LVEF (rs = -0.29, p = 0.22) or GLS (rs = 0.10, p = 0.67), highlighting the value of tissue characterization beyond functional assessment. Nine patients (45%) met full Updated Lake Louise Criteria and 85% met at least one criterion, suggestive of myocarditis in the correct clinical context. Thirteen patients (65%) were treated for ICI-associated myocarditis and, of these, 54% (n = 7) had recovery of LVEF to normal. There was no correlation between LVEF (p = 0.47), GLS (0.89), or % LGE (0.15) and recovery of LVEF with treatment.<h4>Conclusion</h4>In patients with suspected ICI cardiotoxicity, CMR is an important diagnostic tool, even in the absence of overt left ventricular dysfunction, as abnormalities in left ventricular strain, T2 signal and LGE can identifying disease. |
format |
article |
author |
Angela Y Higgins Amit Arbune Aaron Soufer Elio Ragheb Jennifer M Kwan Jerome Lamy Mariana Henry Jason R Cuomo Ahmad Charifa Cesia Gallegos Sarah Hull Jessica Shank Coviello Anna S Bader Dana C Peters Steffen Huber Hamid R Mojibian Albert J Sinusas Harriet Kluger Lauren A Baldassarre |
author_facet |
Angela Y Higgins Amit Arbune Aaron Soufer Elio Ragheb Jennifer M Kwan Jerome Lamy Mariana Henry Jason R Cuomo Ahmad Charifa Cesia Gallegos Sarah Hull Jessica Shank Coviello Anna S Bader Dana C Peters Steffen Huber Hamid R Mojibian Albert J Sinusas Harriet Kluger Lauren A Baldassarre |
author_sort |
Angela Y Higgins |
title |
Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. |
title_short |
Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. |
title_full |
Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. |
title_fullStr |
Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. |
title_full_unstemmed |
Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. |
title_sort |
left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/d60485952e1846e2a5ebdde4efb2f722 |
work_keys_str_mv |
AT angelayhiggins leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT amitarbune leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT aaronsoufer leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT elioragheb leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT jennifermkwan leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT jeromelamy leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT marianahenry leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT jasonrcuomo leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT ahmadcharifa leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT cesiagallegos leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT sarahhull leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT jessicashankcoviello leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT annasbader leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT danacpeters leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT steffenhuber leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT hamidrmojibian leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT albertjsinusas leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT harrietkluger leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity AT laurenabaldassarre leftventricularmyocardialstrainandtissuecharacterizationbycardiacmagneticresonanceimaginginimmunecheckpointinhibitorassociatedcardiotoxicity |
_version_ |
1718374913095499776 |